Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Udenafil and Portal Flow in Cirrhotic Patients with Portal Hypertension
DRKS00003070Phase 2Completed
- Sponsor
- STZ 1172 Gesundheitsförderung und Stoffwechselforschung
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of udenafil in Portal Hypertension (PH) and Cirrhosis (2 arms), sponsored by STZ 1172 Gesundheitsförderung und Stoffwechselforschung. Primary endpoint: Change in portal blood flow after udenafil versus placebo. Started May 2013; status: completed.
02
Drugs
udenafil
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on DRKS00003070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003070.